The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

被引:130
作者
Fremeaux-Bacchi, V
Kemp, EJ
Goodship, JA
Dragon-Durey, MA
Strain, L
Loirat, C
Deng, HW
Goodship, THJ
机构
[1] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[2] Hop Europeen Georges Pompidou, Serv Immunol Biol, Paris, France
[3] Hop Robert Debre, Serv Nephrol, F-75019 Paris, France
[4] Creighton Univ, Med Ctr, Osteoporosis Res Ctr, Genet Lab, Omaha, NE USA
关键词
D O I
10.1136/jmg.2005.030783
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: In both familial and sporadic atypical haemolytic-uraemic syndrome (aHUS), mutations have been reported in regulators of the alternative complement pathway including factor H (CFH), membrane cofactor protein (MCP), and the serine protease factor I (IF). A characteristic feature of both MCP and CFH associated HUS is reduced penetrance and variable inheritance; one possible explanation for this is that functional changes in complement proteins act as modifiers. Objective: To examine single nucleotide polymorphisms in both CFH and MCP genes in two large cohorts of HUS patients (Newcastle and Paris). Results: In both cohorts there was an association with HUS for both CFH and MCP alleles. CFH and MCP haplotypes were also significantly different in HUS patients compared with controls. Conclusions: This study suggests that there are naturally occurring susceptibility factors in CFH and MCP for the development of atypical HUS.
引用
收藏
页码:852 / 856
页数:5
相关论文
共 26 条
[1]   Endothelial cell activation [J].
Ballermann, BJ .
KIDNEY INTERNATIONAL, 1998, 53 (06) :1810-1826
[2]  
BREMEAUXBACCHI V, 2004, J MED GENET, V41, pE84
[3]   Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome [J].
Buddles, MRH ;
Donne, RL ;
Richards, A ;
Goodship, J ;
Goodship, THJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (05) :1721-1722
[4]   Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease [J].
Caprioli, J ;
Castelletti, F ;
Bucchioni, S ;
Bettinaglio, P ;
Bresin, E ;
Pianetti, G ;
Gamba, S ;
Brioschi, S ;
Daina, E ;
Remuzzi, G ;
Noris, M .
HUMAN MOLECULAR GENETICS, 2003, 12 (24) :3385-3395
[5]  
Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297
[6]   Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor [J].
Donne, RL ;
Abbs, I ;
Barany, P ;
Elinder, CG ;
Little, M ;
Conlon, P ;
Goodship, THJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (06)
[7]   Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome [J].
Dragon-Durey, MA ;
Loirat, C ;
Cloarec, S ;
Macher, MA ;
Blouin, J ;
Nivet, H ;
Weiss, L ;
Fridman, WH ;
Frémeaux-Bacchi, V .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :555-563
[8]   Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis:: Report and genetic analysis of 16 cases [J].
Dragon-Durey, MA ;
Frémeaux-Bacchi, V ;
Loirat, C ;
Blouin, J ;
Niaudet, P ;
Deschenes, G ;
Coppo, P ;
Fridman, WH ;
Weiss, L .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03) :787-795
[9]   Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 [J].
Esparza-Gordillo, J ;
de Jorge, EG ;
Buil, A ;
Berges, LC ;
López-Trascasa, M ;
Sánchez-Corral, P ;
de Córdoba, SR .
HUMAN MOLECULAR GENETICS, 2005, 14 (05) :703-712
[10]   Challenges in the management of infantile factor H associated hemolytic uremic syndrome [J].
Filler, G ;
Radhakrishnan, S ;
Strain, L ;
Hill, A ;
Knoll, G ;
Goodship, TH .
PEDIATRIC NEPHROLOGY, 2004, 19 (08) :908-911